What it's for (Indications)
- Choline salicylate + cetalkonium gel is primarily indicated for the symptomatic relief of pain and discomfort associated with common inflammatory conditions of the oral cavity.
- This includes the localized management of mouth ulcers (aphthous stomatitis), cold sores (herpes simplex labialis) in their non-vesicular stages, sore gums, denture irritation, and gingivitis.
- The formulation is designed to provide topical analgesic, anti-inflammatory, and antiseptic actions directly to the affected mucosal areas.
- Its use aims to reduce pain, diminish inflammation, and provide a local antiseptic barrier against potential secondary infections in minor oral lesions, thereby promoting comfort and facilitating healing.
- It is intended for short-term, localized application to address acute discomfort rather than for chronic or widespread oral conditions, and its use should be guided by specific age recommendations and contraindications.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For adults and adolescents aged 16 years and over, a small amount of gel (approximately 0.5-1 cm, or a pea-sized amount) should be dabbed directly onto the affected area of the gum or oral mucosa using a clean fingertip. This application can be repeated every three to four hours, as necessary, but should not exceed six applications within a 24-hour period. It is crucial to adhere strictly to the recommended dosage and frequency to minimize potential systemic absorption of choline salicylate. The gel should not be rubbed vigorously into the tissue. After application, hands should be washed thoroughly. For denture irritation, a small amount of gel should be applied to the gum area and allowed to set before reinserting the dentures; dentures should not be reinserted immediately after application to avoid accidental ingestion or rapid removal of the medication. This medication is not recommended for children under 16 years of age due to the risk of Reye's Syndrome. |
Safety & Warnings
Common Side Effects
- Commonly reported side effects are localized and typically mild, including a transient stinging, burning sensation, or irritation at the site of application.
- These reactions usually subside shortly after application.
- Hypersensitivity reactions, though rare, can manifest as skin rash, itching, swelling (particularly of the face, tongue, or throat), severe dizziness, or trouble breathing.
- Should any signs of allergic reaction occur, discontinue use immediately and seek urgent medical attention.
- While systemic absorption of choline salicylate from topical oral application is generally minimal, excessive or prolonged use, especially on extensive or broken mucosal surfaces, may rarely lead to systemic salicylate effects.
- Symptoms of salicylate toxicity can include tinnitus (ringing in the ears), dizziness, headache, nausea, vomiting, or gastrointestinal discomfort.
- Patients with a history of asthma or salicylate sensitivity may experience exacerbated respiratory symptoms.
- If any severe or persistent side effects are experienced, medical advice should be sought promptly.
Serious Warnings
- Black Box Warning: **WARNING: RISK OF REYE'S SYNDROME** This product contains choline salicylate, a salicylate derivative. Salicylates have been associated with a rare but serious condition known as Reye's Syndrome in children and adolescents (typically under 16 years of age), especially when used during or after recovery from viral illnesses such as influenza (flu) or chickenpox. Reye's Syndrome can cause severe damage to the brain and liver, leading to encephalopathy, liver dysfunction, and can be fatal. **THEREFORE, CHOLINE SALICYLATE + CETALKONIUM GEL IS ABSOLUTELY CONTRAINDICATED FOR USE IN CHILDREN AND ADOLESCENTS UNDER 16 YEARS OF AGE.** Caregivers must be explicitly warned against administering this product to pediatric patients in this age group under any circumstances. If signs of Reye's Syndrome, such as persistent vomiting, lethargy, or behavioral changes, occur in any individual, particularly after viral illness, discontinue use of any salicylate-containing product and seek immediate medical attention. The risk, though primarily associated with systemic salicylate use, necessitates this stringent warning for all routes of administration due to potential mucosal absorption.
- This product should be used with extreme caution and is generally not recommended for individuals under 16 years of age due to the risk of Reye's Syndrome, a rare but serious condition associated with salicylate use in children and adolescents, particularly those recovering from viral infections like influenza or chickenpox.
- Patients with a known hypersensitivity to salicylates, other NSAIDs, or any component of the formulation should avoid this product.
- Caution is advised in individuals with asthma, nasal polyps, or a history of allergic reactions to aspirin or other NSAIDs due to potential cross-reactivity.
- Although systemic absorption is generally low, patients on anticoagulant therapy (e.
- g.
- , warfarin) should consult a healthcare professional before use due to the theoretical risk of increased bleeding.
- Avoid contact with eyes; if accidental contact occurs, rinse thoroughly with water.
- Do not apply to large areas of the oral mucosa or for prolonged periods without medical consultation.
- If symptoms persist for more than 7 days, worsen, or if new symptoms develop, discontinue use and seek medical advice.
- Pregnant or breastfeeding women should consult their doctor before using this product.
How it Works (Mechanism of Action)
Choline salicylate + cetalkonium gel combines two active pharmaceutical ingredients to provide synergistic therapeutic effects. Choline salicylate, a derivative of salicylic acid, functions as a non-steroidal anti-inflammatory drug (NSAID). Its primary mechanism of action involves the inhibition of cyclooxygenase (COX) enzymes, particularly COX-1 and COX-2, which are responsible for the biosynthesis of prostaglandins. Prostaglandins are key mediators of pain, inflammation, and fever. By reducing prostaglandin production locally, choline salicylate effectively diminishes pain perception and attenuates the inflammatory response in the oral mucosa. Cetalkonium chloride is a quaternary ammonium compound that acts as a topical antiseptic. Its mechanism of action involves disrupting the integrity of microbial cell membranes, leading to leakage of intracellular components and subsequent bacterial cell death. This antiseptic action helps to prevent or control minor bacterial infections that can complicate oral lesions, contributing to improved healing and hygiene in the affected area.
Commercial Brands (Alternatives)
No other brands found for this formula.